MHCD.TO Middlefield Healthcare Dividend ETF
The fund aims for stable monthly cash distributions and long-term returns by investing in dividend-paying securities of global companies operating in, or deriving a significant portion of their revenue or earnings, from products and services related to healthcare, life sciences, and other similar industries. The fund adviser believes these industries could to potentially generate strong risk-adjusted returns and present long-term investment opportunities by benefitting from a growing population with aging demographics, longer life expectancies, rising healthcare utilization, and increased spending on the treatment and prevention of chronic illnesses.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| MHCD.TO | +1.4% | +2.1% | +12.5% | +12.8% | +8.3% | +2.8% |
| Equity average (1460 funds) | -5.4% | -4.7% | +1.4% | +3.9% | +11.9% | +4.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$68K net.
Holdings · as of Nov 21, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY Eli Lilly & Company | 7.23% |
| 2 | JNJ Johnson & Johnson | 6.49% |
| 3 | ABBV AbbVie Inc. | 5.29% |
| 4 | MRK Merck & Co., Inc. | 4.69% |
| 5 | AZN.L AstraZeneca PLC | 4.02% |
| 6 | TMO Thermo Fisher Scientific Inc. | 3.80% |
| 7 | SYK Stryker Corp. | 3.02% |
| 8 | DHR Danaher Corp. | 2.75% |
| 9 | NOVN.SW Novartis AG | 2.72% |
| 10 | UNH UnitedHealth Group Inc. | 2.66% |
| 11 | EXE.TO Extendicare Inc. | 2.60% |
| 12 | ISRG Intuitive Surgical Inc. | 2.58% |
| 13 | CSH-UN.TO Chartwell Retirement Residences | 2.52% |
| 14 | ABT Abbott Laboratories | 2.40% |
| 15 | 0Y6X.L Medtronic PLC | 2.36% |
| 16 | MHCD.TO Cash | 2.15% |
| 17 | VRTX Vertex Pharmaceuticals Inc. | 2.13% |
| 18 | RO.SW Roche Holding AG | 2.11% |
| 19 | BMY Bristol-Myers Squibb Co. | 2.05% |
| 20 | NTRA Natera Inc. | 1.98% |
| 21 | MCK McKesson Corp. | 1.93% |
| 22 | HUM Humana Inc. | 1.92% |
| 23 | APTX.TO Apotex Health Corp. | 1.87% |
| 24 | PFE Pfizer Inc. | 1.78% |
| 25 | AMGN Amgen Inc. | 1.75% |
| 26 | ZBIO Zenas Biopharma Inc. | 1.74% |
| 27 | GILD Gilead Sciences Inc. | 1.73% |
| 28 | SAN.PA Sanofi S.A. | 1.72% |
| 29 | INCY Incyte Corp. | 1.58% |
| 30 | JAZZ Jazz Pharmaceuticals PLC | 1.54% |
| 31 | PVLA Palvella Therapeutics Inc. | 1.54% |
| 32 | BBIO Bridgebio Pharma Inc. | 1.53% |
| 33 | IONS Ionis Pharmaceuticals Inc. | 1.52% |
| 34 | EW Edwards Lifesciences Corp. | 1.49% |
| 35 | RLAY Relay Therapeutics Inc. | 1.45% |
| 36 | IMNM Immunome Inc. | 1.35% |
| 37 | 4502.T Takeda Pharmaceutical Co., Ltd. | 1.27% |
| 38 | CAH Cardinal Health Inc. | 1.15% |
| 39 | INBX Inhibrx Biosciences Inc. | 1.08% |
| 40 | WAT Waters Corporation | 1.03% |
| 41 | REGN Regeneron Pharmaceuticals Inc. | 1.03% |
| 42 | DXCM Dexcom Inc. | 0.95% |
| 43 | ALNY Alnylam Pharmaceuticals Inc. | 0.91% |
| 44 | AXSM Axsome Therapeutics Inc. | 0.89% |
| 45 | 4568.T Daiichi Sankyo Co., Ltd. | 0.86% |
| 46 | EGTX.ST Egetis Therapeutics AB | 0.36% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 31, 2026 | C$0.0500 |
| Nov 30, 2026 | C$0.0500 |
| Oct 30, 2026 | C$0.0500 |
| Sep 30, 2026 | C$0.0500 |
| Aug 31, 2026 | C$0.0500 |
| Jul 31, 2026 | C$0.0500 |
| Jun 30, 2026 | C$0.0500 |
| May 29, 2026 | C$0.0500 |
| Apr 30, 2026 | C$0.0500 |
| Mar 31, 2026 | C$0.0500 |
| Feb 27, 2026 | C$0.0500 |
| Jan 30, 2026 | C$0.0500 |
| Dec 31, 2025 | C$0.0500 |
| Nov 28, 2025 | C$0.0500 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in MHCD.TO in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 22, 2026. This is historical data, not investment advice. Report a data error
